CytoMed Therapeutics holder proposes $103K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
A proposed sale of 117,337 CytoMed Therapeutics Ltd (GDTC) ordinary shares was reported for mDR Ltd, identified as a 10% stockholder. The proposed sale has an aggregate market value of $103,256.56 and an approximate sale date of August 11, 2026. mDR Ltd held 1,221,523 ordinary shares immediately before the notice. Edward Lee Ewe Ming signed the notice.
Key Figures
Key Terms
Aggregate Market Value financial
10% Stockholder regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.